MSF Field Research >
1 Published Research and Commentary >
The case for reactive mass oral cholera vaccinations
this identifier to cite or link
to this item:
|Title: ||The case for reactive mass oral cholera vaccinations|
|Affiliation: ||International Vaccine Institute (IVI), Seoul, Korea; Epicentre, Paris, France; NICED, Kolkata, India; Ministry of Health and Social Welfare, Zanzibar, Tanzania; Menzies School of Health Research, Casuarina, Australia|
|Citation: ||PLoS Negl Trop Dis 2011;5(1):e952|
|Journal: ||PLoS Neglected Tropical Diseases|
|Issue Date: ||25-Jan-2011 |
|PubMed ID: ||21283614|
|Additional Links: ||http://www.plosntds.org/article/info%3Adoi%2F10.1371%2Fjournal.pntd.0000952|
|Submitted date: ||2011-04-29|
|Abstract: ||The outbreak of cholera in Zimbabwe intensified interest in the control and prevention of cholera. While there is agreement that safe water, sanitation, and personal hygiene are ideal for the long term control of cholera, there is controversy about the role of newer approaches such as oral cholera vaccines (OCVs). In October 2009 the Strategic Advisory Group of Experts advised the World Health Organization to consider reactive vaccination campaigns in response to large cholera outbreaks. To evaluate the potential benefit of this pivotal change in WHO policy, we used existing data from cholera outbreaks to simulate the number of cholera cases preventable by reactive mass vaccination.|
Aged, 80 and over
|Rights: ||Archived with thanks to PLoS Neglected Tropical Diseases and its Open Access policy.|
|Appears in topics: ||Vaccination|
|Related articles on PubMed|
Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study.
Khatib AM, Ali M, von Seidlein L, Kim DR, Hashim R, Reyburn R, Ley B, Thriemer K, Enwere G, Hutubessy R, Aguado MT, Kieny MP, Lopez AL, Wierzba TF, Ali SM, Saleh AA, Mukhopadhyay AK, Clemens J, Jiddawi MS, Deen J
First outbreak response using an oral cholera vaccine in Africa: vaccine coverage, acceptability and surveillance of adverse events, Guinea, 2012.
Luquero FJ, Grout L, Ciglenecki I, Sakoba K, Traore B, Heile M, Dialo AA, Itama C, Serafini M, Legros D, Grais RF
|See all 203 articles|
All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.